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Summary For patients with refractory epilepsy it is important to search for
alternative treatments. One of these potential treatments could be introducing
new cells or modulating endogenous neurogenesis to reconstruct damaged epileptic
circuits or to bring neurotransmitter function back into balance. In this review the
scientific basis of these cell therapy strategies is discussed and the results are
critically evaluated. Research on cell transplantation strategies has mainly been
performed in animal models for temporal lobe epilepsy, in which seizure foci or
seizure propagation pathways are targeted. Promising results have been obtained,
although there remains a lot of debate about the relevance of the animal models, the
appropriate target for transplantation, the suitable cell source and the proper time
point for transplantation. From the presented studies it should be evident that
transplanted cells can survive and sometimes even integrate in an epileptic brain
and in a brain that is subjected to epileptogenic interventions. There is evidence that
transplanted cells can partially restore damaged structures and/or release substances
that modulate existent or induced hyperexcitability. Even though several studies show
encouraging results, more studies need to be done in animal models with spontaneous
seizures in order to have a better comparison to the human situation.
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Epilepsy is characterized by recurrent unprovoked
seizures and affects 0.5—1% of the population.1,2
More than 30% of the epilepsy patients have uncon-
trolled seizures or unacceptable medication-related
side effects despite adequate pharmacological
treatment.2 These patients have ‘refractory epi-
lepsy’. The underlying pathophysiological process
that transforms a normal brain into an epileptic
brain is termed epileptogenesis.
Epilepsy surgery is an invasive but often curative
treatment option that aims at removing the ictal
onset zone, believed to be responsible for seizure
occurrence.3 For patients in whom the ictal onset
zone is not well circumscribed or localized in func-
tional brain tissue, few treatment options are left.
The inability to adequately treat all patients with
refractory epilepsy provides a continuous impetus to
investigate novel forms of treatment.
A possible alternative way of treating refractory
patients involves neuromodulation through neuro-
stimulation. In our group, we have demonstrated
the efficacy and safety of vagus nerve stimulation
(VNS) and deep brain stimulation (DBS) in both
patients and experimental animal models for epi-
lepsy.4—8 Other possible alternative treatments are
newly developed AEDs,9 the ketogenic diet10,11 and
transcranial magnetic stimulation.12 In spite of all
these developments, a significant number of
patients continue to have uncontrolled seizures
which makes a further search for alternative treat-
ments mandatory.13
A promising treatment option that also receives
considerable attention in other neurodegenerative
diseases (e.g. Parkinson’s Disease) is cell ther-
apy.14,15 In general, there are two main strategies
that involve the use of cells for the treatment of
brain disorders. Firstly, cells can be transplanted to
replace lost neurons and/or to release disease
modifying substances. Secondly, endogenous cells
can be manipulated to affect and modify the
disease process.Temporal lobe epilepsy (TLE) is the most preva-
lent form of refractory symptomatic epilepsy.16
Because of its focal nature and the associated cel-
lular defects this epilepsy syndrome is highly attrac-
tive to be treated with cell therapy. This review will
highlight the most typical cellular alterations in TLE
and then discuss various cell therapy strategies
including neural grafting to reconstruct damaged
epileptic networks, stimulation of endogenous
repair and cell transplantation for local delivery
of seizure suppressing substances.Cellular basis and animal models of
temporal lobe epilepsy
Although the exact cause for the development of
seizures in TLE is still under debate, human TLE is
very frequently associated with specific pathophy-
siological changes that are believed to play an
important role in the generation or intensification
of the epileptic state.
The most frequent lesion in human TLE and
status epilepticus (SE) models is hippocampal
sclerosis, evident in up to 90% of surgically
resected hippocampi.17 Hippocampal sclerosis is
characterized by extensive gliosis combined with
a selective loss of neurons in the dentate gyrus and
the hippocampus proper. Neuronal loss involves
both glutamatergic neurons (granule cells in den-
tate gyrus, pyramidal neurons in hippocampus
proper) and inhibitory interneurons in dentate
hilus and CA1 region. Neuronal cell loss and gliosis
can extend to other mesiotemporal regions such as
amygdala, entorhinal, perirhinal and temporopolar
cortex.18—22 Most affected neurons are pyramidal
neurons of CA1 and CA3 region, excitatory mossy
cells in the hilus, and GABAergic inhibitory inter-
neurons also expressing somatostatin, parvalbu-
min, or neuropeptide Y. Especially the loss of
inhibitory interneurons is believed to be a key
factor underlying the increased excitability of
the epileptic hippocampus.23,24
Cell therapy for TLE 567Mossy fiber sprouting is the growth of aberrant
collaterals of granule cell axons (also called mossy
fibers) into the inner molecular layer of the dentate
gyrus where they preferentially make synaptic con-
nections with dendrites of other granule neurons,
forming excitatory feedback loops.25,26 Mossy fiber
sprouting is presumably caused by the loss of normal
postsynaptic targets of the granule neurons. One of
thearguments for this hypothesis is that thedegreeof
mossy fiber sprouting is correlated to the degree of
neuronal loss in hippocampal sclerosis.27 Electrophy-
siological studies on human hippocampal slices and
experimental studies in animal models for TLE have
shown that the extend of mossy fiber sprouting is
correlated with excitability of the hippocampus.28,29
By far the most used animal model for TLE
demonstrating spontaneous seizures and typical
brain damage is the status epilepticus (SE) model.
In this model a SE is evoked by systemic or intracer-
ebral injection of excitotoxins (kainic acid or pilo-
carpine) or by tetanic electrical stimulation of
temporal lobe structures. After a latent period,
during which epileptogenesis is occurring, sponta-
neous seizures are displayed.30
Another commonly used model for TLE is the
kindling model. In this model temporal lobe struc-
tures are repeatedly stimulated by short electrical
pulse trains. The animals respond to the stimulation
by displaying an electrical discharge on the EEG
(afterdischarge) and abnormal behaviour. With
increasing number of stimulations rats display more
complex afterdischarges or more severe seizures.
Rats consistently displaying tonic—clonic seizures
are termed fully kindled. Spontaneous seizures are
only seen after a large amount of stimulations but
even then gross morphological damage, seen in the
status epilepticus model, are not or only moderately
evident. Based on the controlled induction of epilep-
togenesis, the kindling model is a very interesting
tool to study the role of events associated with
epileptogenesis.31 Frequently used parameters to
assess efficacy of treatments in this model are the
current intensity needed to evoke an afterdischarge,
termedafterdischarge threshold (ADT), and thenum-
ber of stimulations needed to fully kindle the rats,
termed kindling rate.Structural repair of damaged epileptic
networks
Cell transplantation for repair of
hippocampal circuitry
In case of TLE, the sclerotic hippocampus is the most
obvious target for circuitry reconstruction given itspresumed role in the TLE.21 However, mediating
structural repair of damaged hippocampal networks
to restore balance between excitation and inhibi-
tion is without doubt an enormous challenge. As
already described higher, hippocampal sclerosis
involves the loss of different types of both excita-
tory and inhibitory neurons in different regions
throughout the hippocampal structure. Therefore,
cellular repair of hippocampal sclerosis will prob-
ably require multiple grafts of different cell types
throughout the hippocampal structure.
Successful reestablishment of balanced excita-
tory drive and inhibitory input will demand a great
deal of the transplanted cells. They will need to: (1)
survive; (2) disperse and/or migrate to appropriate
cell layers; (3) generate appropriate phenotypes in
correct relative numbers and at the proper locations
in the hippocampus; (4) attract suitable afferent
input and (5) establish appropriate local and long
distance connections with the proper target host
and grafted neurons.
The need for proper integration is evident from
electrophysiological studies in sclerotic hippocampi
which showed that endogenous neurons which dis-
play inappropriate synaptic connectivity25,32 and/or
integrate at ectopic locations in the hippocampus33
are part of hyperexcitable networks. It is therefore
very likely that grafted neurons which do not inte-
grate properly could enhance excitability rather
than suppressing it.
Indeed, there have been reports which demon-
strated pro-epileptic effects of hippocampal trans-
plantation. In a series of experiments, Buzsaki et al.
transplanted foetal hippocampal tissue chunks or
dissociated foetal hippocampal tissue into intact34
or fimbria—fornix lesioned, seizure-prone hippo-
campus.35—40 By performing electrophysiological
recordings the authors found that reciprocal elec-
trophysiological connectivity was established
between the graft and the intact or lesioned host
brain. However, they found that the most typical
EEG pattern in the transplant was highly synchro-
nous bursting behaviour with concurrent large
amplitude EEG spikes. Spontaneous EEG seizures
were also frequently recorded from the graft which
spread into the host brain.35,36 Moreover, sponta-
neous behavioural convulsions were detected in a
high fraction of the transplanted rats.34,37,39
Although the exact mechanism for this trans-
plantation-induced epileptiform activity was not
unravelled, the authors suggested that the hyper-
excitability of the graft was caused by a lack of
afferent control, extensive formation of recurrent
excitatory circuitry and insufficient GABAergic
inhibition within the graft.37 Buzsaki and collea-
gues hypothesized that the grafted hippocampal
568 R. Raedt et al.cells served as an epileptic focus that kindled the
host brain by repeated seizure induction.34,39
Foetal hippocampal cell transplantation
In spite of the hurdles, described in the previous
chapter, foetal hippocampal neurons have been
transplanted into the hippocampus of the intraven-
tricular kainic acid model.41—48 In this model there
is selective loss of CA3 pyramidal neurons41 and
subsequent expression of spontaneous limbic
seizures.49,50
A considerable fraction of the transplanted foetal
hippocampal cells was able to survive upon trans-
plantation in the damaged CA3 region. However, this
survival was severely influenced by postlesion delay
(PLD), age of the rats and the type of transplanted
cells. Highest survival rates (77%) were seen when
foetal CA3 cells were transplanted in young mature
rats with a PLD of 4 days.41 However if the PLD was
longer, the fraction of surviving cells was much
lower (e.g. 21—31% if PLD was 45 days).51 Survival
in case of transplantation with longer PLD could be
dramatically enhanced (up to 99%) by pre-treating
the cells with a cocktail of growth factors and an
anti-apoptotic factor.52 Survival rates of trans-
planted cells also strongly depended on cell speci-
ficity. Survival of CA1 cells, transplanted into the
damaged CA3 region, was much lower compared to
that of CA3 cells after a PLD of 4 days (respectively
42% and 77%). When fetal striatal cells were trans-
planted survival was even worse (only 4 to 12%).46
The migration of foetal hippocampal cells upon
transplantation was minimal with the cells remain-
ing clumped at the grafting site.54,55 By using retro-
grade tracing, Shetty and Turner, showed that
grafted foetal hippocampal CA3 neurons formed
short-distance efferent projections to ipsilateral
CA1 region and entorhinal cortex and long-distance
efferent projections to septum and contralateral
hippocampus.41 However, efferent projections to
contralateral hippocampus were only seen in case
of homotopic grafting, which means grafting of CA3
neurons in proximity of the damaged CA3 region. If
CA3 neurons were transplanted in the CA1 regions
or CA1 neurons in the damaged CA3 region no long
distance projections towards contralateral hippo-
campus were found.42,44 Growth of host afferent
projections into the cluster of grafted cells was
also demonstrated. Using histochemical staining
and anterograde labelling, afferent cholinergic
fibers, mossy fibers and commissural fibers of con-
tralateral CA3 neurons were found in the transplan-
tation area.41 Highest density of afferent fibers in
the transplant was seen in case of homotopic graft-
ing. The authors hypothesized that the need forhomotopic grafting could be due to the fact that
axon guidance pathways in the host may be highly
specific, requiring accurate placements of the
grafts to achieve access.56 Both the limited migra-
tion and the need for homotopic grafting are very
important disadvantages for potential repair of
damaged hippocampal circuitry using foetal hippo-
campal neurons.
Nevertheless, if foetal CA3 neurons were trans-
planted homotopically, transplantation could result
in partial reversal of secondary pathological altera-
tions including aberrant mossy fiber sprouting, pos-
sibly by providing an appropriate target.43,52
Additionally, loss of glutamic acid decarboxylase
(GAD) positive interneurons could be reversed. As
the graft did not seem to donate the GAD-positive
cells, the authors hypothesized that the loss of CA3
afferents led to a downregulation of GAD protein
expression, which was reversed by replacing CA3
cells.45
Unfortunately in their series of experiments the
authors did not perform electrophysiological analy-
sis of connectivity, so it remains uncertain whether
the transplanted cells also functionally integrated.
They also did not monitor for epileptic activity so it
is not clear whether grafting of foetal CA3 neurons
and the reversal of some pathological secondary
changes resulted into a normalization of the imbal-
ance between excitation and inhibition or a dam-
pening of the epileptic activity.
Neural stem/progenitor cell
transplantation
Transplantation of foetal brain tissue has important
limitations which will probably always limit its
application on a large clinical scale. These limita-
tions include the inability to expand or store foetal
cells, resulting in a high number of foetuses needed
for one single transplantation (e.g. 6—8 fetal donors
to tread one PD patient).57 Another limitation is that
purity and viability of the transplant is difficult to
control so that outcome of transplantation is highly
variable.58 Moreover, as already described in the
previous chapter, transplanted foetal cells have
very limited migratory capabilities and homotopic
grafting seems to be required.
Because neural stem/progenitor cells are self-
renewing cells which can migrate throughout the
brain and are able to generate different neuronal
progeny, they could, at least in theory, overcome
the limitations of foetal tissue and be a promising
alternative cell source. Transplantable neural stem/
progenitor cells can be derived in several ways from
different sources. They can be produced almost
completely in vitro starting from embryonic stem
Cell therapy for TLE 569cells (ESC) using specific differentiation proto-
cols.59—68 Expandable neural progenitor cells can
also be generated by immortalizing neuroepithelial
precursor cells, derived from defined embryonic
regions, prior to their terminal mitosis. This can
be done by transfecting the cells with a vector
containing a transcript encoding for a (temperature
sensitive) immortalizing oncogene.69,70 Neural
stem/progenitor cells can also be isolated directly
from different regions of the embryonic central
nervous system (CNS) but also from restricted areas
in the adult brain such as hippocampus, SVZ, stria-
tum, substantia nigra, cortex, spinal cord, septum
and optic nerve.71—78
Following transplantation in the brain, neural
stem/progenitor cells seem to be able to function-
ally integrate into neural networks.79,80 However,
there are only few reports demonstrating the ability
of neural stem/progenitor cells to functionally
replace lost neurons and reconstruct damaged cir-
cuitry.81 Transplantation for stroke seems to bemost
successful with reports on migration of neural pro-
genitor cells towards the lesion with formation of
new neurons82 and reestablishment of neural con-
nections with functional recovery.83,84 Systemically
injected neural stem cells, in a model for multiple
sclerosis, migrate to inflammatory demyelinating
lesions, where they can remyelinate axons.85
To our knowledge, studies showing structural
repair of damaged circuitry in sclerotic hippocam-
pus by transplantation of neural stem/progenitor
cells are unavailable. In one study, neural stem
cells, isolated from human embryos, have been
injected systemically one day after induction of
SE with pilocarpine. Transplanted cells were found
in the hippocampus, amygdala and pyriform cortex 6
weeks after transplantation. About 30% of the cells
were immunopositive for GABA and parvalbumin,
two proteins also expressed by inhibitory interneur-
ons. Surprisingly, the grafted cells did not express
the panneural markers Neuronal Nuclei (NeuN) or b-
III-tubulin (b-III-tubulin), indicating that they most
probably were not neurons. Transplantation did
however result in a significant decrease in daily
seizure frequency, seizure severity and the number
of rats that displayed spontaneous seizures. It was
demonstrated that field excitatory postsynaptic
potentials (fEPSP) in the CA1 region were
decreased.86 This indicates that transplantation
could have anti-epileptogenic effects without evi-
dence of structural repair by the transplanted cells.
A conditionally immortalized neural progenitor
cell line, called MHP36, has been developed and has
shown potential to replace, at least in part, CA1
pyramidal neurons in models where the CA1 region
was specifically damaged, either by excitotoxiclesioning87 or ischemia.88 These MHP36 cells were
also transplanted into four sites of the rat brain,
extending from the anterior to the posterior pyri-
form cortex, 3 weeks after SE. However, in this study
no replacement of lost pyramidal CA1 or CA3 neu-
rons was reported but a significant augmentation in
the number of seizures was found after transplanta-
tion.89
In a study, performed at the Ghent University
Hospital, adult SVZ-derived neural stem cells were
transplanted in the lesioned hippocampus of the
intrahippocampal kainic acid SE model.90 Adult
neural stem cells were transplanted 3 days or 3
weeks after the kainic acid lesion. This resulted in
a low (about 1%) but robust survival of the cells for at
least 6 weeks after transplantation. However, only a
fraction of the cells differentiated towards neurons
while the majority of the cells generated astrocyte-
like cells probably contributing to gliosis in response
to the lesion.
Stimulating endogenous repair as a
strategy?
In ischemia models neural replacement by endogen-
ous neural precursors has been demonstrated in
both the striatum and the hippocampus. In the
permanent middle cerebral artery occlusion model
a small number of lost medium spiny interneurons in
the striatum were replaced by endogenous SVZ-
derived progenitor cells.91—93 In the four vessel
occlusion model, transient induction of global ische-
mia leads to selective degeneration of CA1 pyrami-
dal neurons. In this model a fraction of the lost CA1
neurons were replaced by endogenous neural pro-
genitors, migrating from the posterior periventricu-
lar region (PPV) to the damaged CA1 region.94,95
Brief intraventricular infusion of growth factors in
the first week after stroke markedly increased
reconstitution of CA1.94
Recently, enhanced proliferation and migration
of neural precursor cells from the PPV towards
damaged hippocampal CA1 and CA3 regions has
been reported in the pilocarpine SE model for
TLE. However, these neural precursor cells exclu-
sively generated glial cells in the damaged hippo-
campal regions without any indication of neuronal
replacement.96 One strategy that could lead to
promoting endogenous repair of sclerotic hippocam-
pus could be to identify the factors which promote
neuronal replacement in ischemically damaged hip-
pocampus and/or block neuronal replacement in the
sclerotic hippocampus.
In the pilocarpine SE model but also in
other models for TLE, seizure-activity stimulates
neurogenesis in the granule cell layer of the
570 R. Raedt et al.hippocampus.97—100 However, as the granule cell
layer is relatively spared in case of TLE, it is not
yet clear whether this enhanced neurogenesis is an
attempt of the brain to repair damage or whether it
is a part of the epileptogenic process. It seems that a
fraction of the newborn granule cells contributes to
the formation of abnormal circuitry by migrating
towards ectopic locations in the hippocampus,33
contributing tomossy fiber sprouting99 or generating
a persistent basal dendrite which projects into the
hilus and receives synaptic input from sprouted
mossy fibers.101 However, the great majority of
the newborn neurons generated in response to sei-
zures, form granule cells which normally integrate
into the granule cell layer.
In order to further elaborate on the role of
enhanced neurogenesis in response to seizures we
recently performed a study, in collaboration with
the University of Goteborg, in which we blocked
seizure-induced neurogenesis in rats by using low-Table 1 Overview of the transplantation studies with nora
Cell source Model Time point of
transplantation
Fetal LC tissue Kindling after
NA-depletion
2 weeks after
depletion
6—11 months
before kindling
Fetal LC tissue Kindling after
NA-depletion
and intact rats
Fully kindled
Fetal LC tissue Picrotoxin after
NA-depletion
10 days after depletion
5 months before
picrotoxin injection
Fetal LC tissue Subcortically
denervated,
epilepsy-prone
hippocampus
Chronic epilepsy state
Fetal LC tissue Pilocarpine SE +
kindling
2 weeks after SE
6 to 11 months
before kindling
Fetal LC tissue KA SE + kindling 10 days after SE
230 days before
kindling
Fetal LC or
SCG tissue
Kindling after
NA-depletion
and aspirative
lesion of the
fimbria—fornix
4 weeks after depletion
2 weeks after lesion
8 months prekindling
KA: kainic acid; LC: locus coeruleus; TLE: temporal lobe epilepsy;
epilepticus.dose brain radiation one day before hippocampal
kindling. We found that suppression of seizure-
induced neurogenesis did not slow down of prevent
kindling, indicating that new neurons generated in
response to seizures play no major role in kindling
epileptogenesis.102 We believe that further studies
are needed in other models to further unravel the
role of granule cell neurogenesis in TLE before
strategies for suppressing or enhancing endogenous
hippocampal neurogenesis could be developed.Cell grafting for local delivery of
seizure suppressing substances
Several neurotransmitters and neuromodulators
have anticonvulsant effects. Because they are
synthesized and secreted by brain derived cells in
normal physiological conditions, they are suitable
candidates for cell based delivery therapy. Accordingdrenaline releasing cells
Target Effect on seizures References
Hippocampus Lower kindling rate Barry
et al.106
Hippocampus No effect on
seizure rate
Bengzon
et al.108
Hippocampus Protection against
picrotoxin induced
seizures, less
interictal spikes
Bus
et al.37
Hippocampus Reduction in
spontaneous seizures
Bortolotto
et al.111
Amygdala or
pyriform cortex
Decrease of
kindling rate
Barry
et al.109
Intracerebro-
ventricular
Same fraction of
epileptic rats;
lower seizure
frequency; no
effect on kindling rate
Holmes
et al.112
Fimbria—fornix
lesion cavity
Lower (LC tissue)
or no effect
(SCG tissue)
on kindling rate
Kokaia
et al.105
NA: noradrenaline; SCG: superior cervical ganglion; SE: status
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Table 2 Overview of the transplantation studies with acetylcholine releasing cells
Cell source Model Time point of
transplantation
Target Effect on
seizures
References
Fetal basal
forebrain tissue
PTZ and audiogenic
stimulation after
lesion of the
fimbria-fornix
10 days after lesion Hippocampus More reactive
to PTZ;
Cassel
et al. 1141 year before epilepsy
induction (PTZ, sound) Less reactive
to sound
Fetal basal
forebrain tissue
PTZ and audiogenic
stimulation after
lesion of the
fimbria-fornix
8—9 days after lesion Hippocampus Less reactive
to PTZ;
Cassel et al.,
19911183, 7 or 12 months before
epilepsy induction
(PTZ, sound)
More reactive
to sound
Septal-diagonal
band tissue
Picrotoxin after 192
IgG-saporin lesioned
basal forebrain system
10 days after lesion Hippocampus Decrease in
kindling rate
Ferencz
et al.1195 months before
picrotoxin injection
PTZ: pentylenetetrazol.to this strategy noradrenaline (NA, Table 1), acet-
ylcholine (AchE; Table 2), GABA (Table 3) and ade-
nosine secreting cells (Table 4) have been
investigated in transplantation studies.
Noradrenaline secreting cells (Table 1)
The inhibitory effects of NA were reported in tem-
poral lobe epileptogenesis. When extracellular NA
levels are artificially augmented by blocking its
uptake or by electric stimulation of the noradrena-
line rich locus coeruleus (LC), there is a significant
attenuation of the kindling rate.103 On the other
hand depletion of the noradrenergic system by
injecting 6-OHDA has facilitating effects on kind-
ling.104 Transplantation of NA-rich foetal LC cells in
the hippocampus of NA depleted rats reversed theTable 3 Overview of the transplantation studies with GAB
Cell source Model Time point of
transplantation
Fetal striatal tissue Amygdala kindling Fully kindled
GABA secreting
cortical neural
cell line
Entorhinal cortex
kindling
10 days before
kindling
GABA secreting
cortical neural
cell line
Entorhinal cortex
kindling
12 days before
kindling
GABA secreting
cortical neural
cell line
Entorhinal
cortex kindling
7—10 days
before kindling
GABA secreting
cortical neural
cell line
Pilocarpine SE 45—65 days
after SE
ADD: afterdischarge duration; ADT: afterdischarge threshold; SE: sfacilitating effect of the lesion but only when NA
release by the graft is under control of the host brain
and sufficient in response to kindling stimula-
tion.105—107 Grafting of NA neurons only affected
kindling epileptogenesis but not fully kindled sei-
zures. Also no anti-epileptic effects could be
demonstrated if the LC tissue was transplanted into
intact hippocampus.108 NA-rich neurons have also
been transplanted in NA depleted rats into extra-
hippocampal regions, such as the amygdala—piri-
form cortex. In this experiment grafting only
affected seizure development if the transplanted
LC neurons re-innervated the host hippocampi bilat-
erally.109 Compared to foetal LC neurons, NA-rich
superior cervival ganglion (SCG) neurons demon-
strated less survival, integration and NA release.110
Therefore transplantation of SCG neurons had littleA releasing cells
Target Effect on seizures References
SN Transient higher ADT Lo¨scher
et al.125Less severe seizures
SN Posterior SN: higher
kindling rate
Thompson
et al.127
Anterior SN: lower
kindling rate
Pyriform
cortex
Increase in ADT Gernert
et al. 128No difference in
kindling rate
Hippocampus Higher ADT Thompson
et al.129Lower ADD
Lower kindling rate
Anterior SN Seizure-suppression
up to 13 days after
transplantation
Thompson
et al.130
tatus epilepticus; SN: substantia nigra.
572 R. Raedt et al.
Table 4 Overview of the transplantation studies with adenosine releasing cells
Cell source Model Time point of
transplantation
Target Effect on seizures References
Encapsulated,
engineered
baby hamster
kidney cells
Hippocampal
kindling
Fully kindled Lateral
ventricle
Day 1—14: almost
complete suppression
of seizures
Huber
et al.137
Day 14—24: gradual
loss of seizure
protection
Encapsulated,
engineered adult
mouse myoblasts
Hippocampal
kindling
Fully kindled Lateral
ventricle
Day 1—7: complete
suppression of seizures
in all rats
Gu¨ttinger
et al. 138
Day 7-week 8: gradual
loss of seizure protection
Encapsulated,
engineered
embryonic stem
cells derived glia
Hippocampal
kindling
Fully kindled Lateral
ventricle
Day 3: complete
suppression of
seizures in all rats
Gu¨ttinger
et al. 140
Day 7: no seizure
suppressionor no effects on kindling rate in NA-depleted rats.105
Transplantation of foetal LC neurons in a hippocam-
pus, which is epilepsy prone due to subcortical
denervation, gave some protection against picro-
toxin-induced behavioural seizures and resulted in
less interictal spikes.37
Foetal LC tissue was also transplanted in the
hippocampus of the pilocarpine-induced SE model.
After transplantation the number of spontaneous
seizures was reduced from approximately 11 per
week to less than 1 per week, with the effect
starting between 5 and 6 weeks after grafting sur-
gery and being maximal at about 9 weeks. However,
no appropriate control groups were used in this
study.111 Milder effects were seen when LC cells
were transplanted in immature rats after kainic
acid-induced SE. In this study, there was no reduc-
tion in the percentage of rats that developed spon-
taneous seizures, but the transplanted rats
displayed fewer spontaneous seizures than sham-
transplanted controls. No difference in susceptibil-
ity to kindling induced seizures was seen eight
months after grafting.112
We can conclude from these studies that NA-
releasing cells can have inhibitory effects on epilep-
togenesis in specific animal models where the hippo-
campus is rendered epilepsy prone. NA releasing
grafts do not seem to have large effects on estab-
lished epilepsy. This limits suitability of NA releasing
cells for possible clinical applications in TLE.
Acetylcholine secreting cells (Table 2)
The septohippocampal system is known to play a
role in the regulation of hippocampal excitability.It comprises the medial septum (MS) and the ver-
tical limb of the diagonal band of Broca (VDB)
which are connected with the hippocampus via
the fimbria—fornix (FF). These projections are pre-
dominantly cholinergic and GABAergic.113 Lesion-
ing the FF increases susceptibility for seizure
development114 and produces chronic epileptiform
activity (interictal spiking and decreased after-
discharge thresholds).115 These epileptogenic
effects are predominantly due to loss of choliner-
gic afferents, since selective immunolesioning of
these afferents with 192 IgG-saporin, induces com-
parable effects.116,117
Where embryonic, acetylcholine (AchE)-rich basal
forebrain tissuewas transplanted in thehippocampus
of fimbria—fornix lesioned rats, contradictory results
were found. Implantation of embryonic basal fore-
brain tissue into the hippocampus of fimbria—fornix
lesioned rats showed that the grafted rats displayed
more severe convulsions in response to the procon-
vulsant pentylenetetrazol (PTZ), but were less reac-
tive to audiogenic stimulation. In this study therewas
only a poor re-innervation of the deafferented hip-
pocampus.114 In a subsequent study opposite effects
were found, with a reduction of the reactivity to PTZ
and an increase of the reactivity to sound. In this
study the authors reported an improved integration
of the graft.118 Due to these conflicting results, con-
clusions about grafting AChE neurons and seizure
susceptibility can not be drawn.
Intrahippocampal transplantation of AChE rich
foetal septal tissue after saporin-induced lesioning
of the forebrain cholinergic system reversed the
lesion-induced facilitation of the kindling rate.119
The authors propose that the suppression of
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to restoration of the cholinergic activation of inhi-
bitory GABAergic interneurons, although there was
no direct proof for this assumption.
In all these studies cholinergic grafts were
implanted before induction of epileptogenesis.
Whether or not grafts of cholinergic-rich neurons
can have anticonvulsive effects after the epileptic
syndrome has been established is still unclear.
GABA releasing cells (Table 3)
Initial evidence that administration of GABA inhibits
seizure activity was reported in studies using neu-
rotransmitter application in dogs.120 Peripheral
administration of GABA or GABA agonists has several
limitations, such as limited capacity to cross the
blood—brain barrier, undesirable side effects and
proconvulsant activity in primates and humans,120
due to the diffuse stimulation of GABAA receptors
within the brain. An alternative to increase GABA
release at the epileptic focus is to implant GABA-
releasing cells.
In different regions of the brain, contributing to
the manifestation of seizures, a consistent loss of
glutamic acid decarboxylase (GAD)-positive inter-
neurons has been demonstrated. These regions are
the substantia nigra pars reticulata (SNr),121,122 the
basolateral amygdala (BLA),123 the striatum,124 the
pyriform cortex (PC),123 and the hippocampus.23,45
GABA releasing cells have been grafted in some of
these structures in different models for TLE.
GABA-rich foetal striatal tissue has been trans-
planted into the SNr of fully amygdala kindled
rats.125 SNr was chosen because of its presumed
role in the spreading of seizure acitivity.126 After
transplantation a significant increase in ADT was
seen. Also a significant decrease in seizure severity
was evident. These seizure-suppressing effects
were transient and disappeared in the weeks follow-
ing transplantation.
As an alternative for foetal GABAergic cells,
Thompson et al. have engineered conditionally
immortalized mouse neurons to deliver GABA by
driving GAD65 expression that could be shut down
by the administration of doxycycline. This cell line
has been transplanted into the SNr,127 the pyriform
cortex128 and the dentate gyrus of the hippocam-
pus129 of rats prior to kindling. The effect of trans-
plantation in the SNr was dependent on the location
within the SNr. Transplantation in the posterior SNr
significantly facilitated kindling development.
When cells were transplanted in the anterior SNr
kindling rate increased but not significantly.127
Transplantation of the cells in the pyriform cortex
caused a temporary increase in ADT and did noteffect kindling rate.128 The reason why this antic-
onvulsant effect was partial and transient could
have several explanations such as a decrease of in
vivo GABA-release, progressive cell death of trans-
planted cells or down regulation of GABA receptors
in the host tissue. Transplantation of the cells in the
hippocampus improved the results. After transplan-
tation an elevation of ADT, a slower entorhinal
kindling rate, a longer latency between entorhinal
stimulation and behavioural seizures was found. The
transplanted cells showed limited survival after
transplantation and were detected only in 30% of
the transplanted animals 3 weeks after grafting.129
These GABA releasing cells have also been trans-
planted into the anterior substantia nigra 45—65
days after pilocarpine induced SE.130 Seven to ten
days following transplantation there was a robust
suppression of behavioural seizures and a reduction
in interictal spikes. The evaluation of the seizure
suppressing effect of GABA releasing transplants
ended 13 days after transplantation, while it would
have been interesting to investigate whether this
anticonvulsant effect was long lasting.
The effect of GABA releasing cells on seizures are
more convincing than earlier studies with NA and
AchE releasing cells. Long-term cell survival and
video-EEG monitoring is required in animal models
with spontaneous seizures in order to evaluate the
duration of the anticonvulsant effect and possible
side effects.
Adenosine releasing cells (Table 4)
Adenosine and its analogues have powerful antisei-
zure and neuroprotective activities.131,132 During
epileptic seizures or status epilepticus, extracellu-
lar adenosine concentrations are elevated. This is
considered to be an endogenous protective mechan-
ism in order to control the ongoing seizure. Unfor-
tunately, during the process of epileptogenesis the
tonic inhibition of adenosine decreases due to down-
regulation of its A1-receptors and increased break
down of adenosine by adenosine kinase.133,134
Because of its great potential to control seizures,
adenosine might be a good alternative substance for
treating epilepsy.
When administered systemically, adenosine and
adenosine agonists cause adverse effects which
have prevented its therapeutic use.135 Therefore
experiments have been set up in which adenosine
was released locally in the brain of kindled rats by
synthetic polymers.136 Analysis of adenosine release
revealed that a release of 20—50 ng/day by the
polymer is sufficient to provide protection against
seizures. The anticonvulsant effects lasted up to
fourteen days after transplantation of the polymer.
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less than 10 ng per day. These experiments showed
that the amounts of adenosine required to locally
suppress seizure activity were in the range, achiev-
able for adenosine released from cell sources. Trans-
plantation of cells that have the capacity to survive
and release adenosine permanently is a promising
tool to achieve a more sustained suppression of
seizure activity. Baby hamster kidney fibroblasts,137
mouse myoblasts138 and mouse embryonic stem cell
derived glia,139,140 all genetically engineered to
release adenosine, have been transplanted in fully
kindled rats. Transplantation of engineered hamster
kidney fibroblasts and mouse myoblasts resulted in
an almost complete suppression of kindled seizures
up to 14 days after transplantation. After 14 days
there was a gradual loss of seizure protection which
could be attributed to a limited survival of the
cells.137,138 This survival dependant effect was even
more evident from the experiments where mouse
embryonic stem cell-derived glial cells were trans-
planted into fully kindled rats. Three days after
transplantation complete suppression of seizures
in 100% of the animals and 90% cell viability was
found. Seven days after transplantation, seizure
suppression was lost and viable cells no longer
detectable.
In all studies seizure-suppressant effects could be
contributed to the adenosine release since injection
of the A1 receptor antagonist DPCPX (8-cyclopentyl-
1,3-dipropyl-xanthine) abolished the adenosine-
induced seizure suppressing effects. From these
studies it is evident that the search for a cell source,
which is able to survive for prolonged time in the
brain while continuously secreting anti-seizure sub-
stances, is of major importance to develop cell
therapies for the treatment of refractory TLE
patients.Conclusion
In TLE, structural changes in the hippocampus are
believed to play a key role in the generation of
epileptic seizures. However, given the complexity
of hippocampal circuitry and cell damage in case of
hippocampal sclerosis, structural repair of epileptic
hippocampal networks will require complex trans-
plantation strategies in which proper integration
and rewiring of the implanted neurons will be of
crucial importance. Foetal hippocampal transplan-
tation has been successful in reversing some patho-
logical changes but important disadvantages, such
as limited migration and the need for homotopic
transplantation, have urged the search for alterna-
tive cell types. Exogenous and endogenous neuralprogenitor cells could be used for the repair hippo-
campal damage. However, increased knowledge
about injury-induced neurogenesis and differentia-
tion pathways will be necessary in order to guide the
cells towards the cell type they have to replace and
prevent them from contributing to pathological
processes such as gliosis.
In another strategy cells are transplanted for the
release of neurotransmitters or neuromodulatory
agents. Transplantation studies for epilepsy have
mainly grafted therapeutic cells before the epilep-
togenesis induction. Although there are already
promising results with certain substances, such
as GABA and adenosine, further in vivo studies
in animal models with spontaneous seizures are
mandatory to initiate extrapolations to the human
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